Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Schürpf

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The EMBO Journal|September 28, 2011
Regulation of integrin affinity on cell surfacesThomas Schürpf, Timothy A Springer
The Journal of Biological Chemistry|September 20, 2013
How natalizumab binds and antagonizes α4 integrinsYamei Yu, Thomas Schürpf, Timothy A Springer
The Journal of Biological Chemistry|October 4, 2011
The C-terminal αI domain linker as a critical structural element in the conformational activation of αI integrinsGabriele Weitz-Schmidt, Thomas Schürpf, Timothy A Springer
The Journal of Biological Chemistry|June 18, 2004
Sialylated complex-type N-glycans enhance the signaling activity of soluble intercellular adhesion molecule-1 in mouse astrocytesVivianne I Otto, Thomas Schürpf, Gerd Folkers, et al.
The Journal of Biological Chemistry|September 19, 2012
Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptorChafen Lu, Li-Zhi Mi, Thomas Schürpf, et al.
Breast Cancer Research and Treatment|November 28, 2002
Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamideA Paula Simões-Wüst, Thomas Schürpf, Jonathan Hall, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 19, 2012
The RGD finger of Del-1 is a unique structural feature critical for integrin bindingThomas Schürpf, Qiang Chen, Jin-Huan Liu, et al.
International Journal of Toxicology|March 19, 2021
Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid TumorsBrian T Welsh, Ryan Faucette, Sanela Bilic, et al.
Glycobiology|August 1, 2006
N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometryVivianne I Otto, Eugen Damoc, Leah N Cueni, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancerJunquan Liu, Huai-Chin Chiang, Wei Xiong, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The EMBO Journal|September 28, 2011
Regulation of integrin affinity on cell surfacesThomas Schürpf, Timothy A Springer
The Journal of Biological Chemistry|September 20, 2013
How natalizumab binds and antagonizes α4 integrinsYamei Yu, Thomas Schürpf, Timothy A Springer
The Journal of Biological Chemistry|October 4, 2011
The C-terminal αI domain linker as a critical structural element in the conformational activation of αI integrinsGabriele Weitz-Schmidt, Thomas Schürpf, Timothy A Springer
The Journal of Biological Chemistry|June 18, 2004
Sialylated complex-type N-glycans enhance the signaling activity of soluble intercellular adhesion molecule-1 in mouse astrocytesVivianne I Otto, Thomas Schürpf, Gerd Folkers, et al.
The Journal of Biological Chemistry|September 19, 2012
Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptorChafen Lu, Li-Zhi Mi, Thomas Schürpf, et al.
Breast Cancer Research and Treatment|November 28, 2002
Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamideA Paula Simões-Wüst, Thomas Schürpf, Jonathan Hall, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 19, 2012
The RGD finger of Del-1 is a unique structural feature critical for integrin bindingThomas Schürpf, Qiang Chen, Jin-Huan Liu, et al.
International Journal of Toxicology|March 19, 2021
Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid TumorsBrian T Welsh, Ryan Faucette, Sanela Bilic, et al.
Glycobiology|August 1, 2006
N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometryVivianne I Otto, Eugen Damoc, Leah N Cueni, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancerJunquan Liu, Huai-Chin Chiang, Wei Xiong, et al.
Pageof 2